Between 2021 and 2023, about 13 firms delisted from the Nigerian Exchange (NGX), due to varying reasons, from breach of regulatory requirements to voluntary delisting. With the cumulative market cap of the companies amounted to N335.5 billion.
GlaxoSmithKline Consumer Nigeria has posted a pre-tax profit of N815.45 million, representing a 34.3% decline from the N1.24 billion posted in FY 2022.
@forteoilng was the worst performing stock this week on the @nsecontact for the trading week ended July 12, 2019
@chams_plc led the losers on the @nsecontact this week, declining by 13.89%
@forteoilng was the best performing stock on the @nsecontact for the trading week ended June 15, 2019
@neminsuranceplc was the worst performing stock this week declining by 13.14% to close at N2.05
Here is a rundown of corporate actions that took place at the @nsenigeria last week and those expected in the week ahead.
@MTNNG leads this week's watchlist due to record demand for the stock by investors, following its listing.
@MTNNG listing on the @nsecontact premium board was the highlight of activities on the Nigerian bourse last week.
GSK Consumer Nigeria has picked Fidson Healthcare Plc as the contract manufacturer of its wellness and respiratory products effective Q3 2021
GSK issued a statement to the Nigerian Stock Exchange in response to a story by Nairametrics. Yet, it had refused to respond to an email from Nairametrics seeking clarification prior to the publication of the story.
Two weeks ago, GSK Consumer Nigeria Plc declared a final dividend of N0.50 per share for the 2018 financial...
